CORALLINI, Federica
 Distribuzione geografica
Continente #
NA - Nord America 4.807
AS - Asia 2.092
EU - Europa 944
SA - Sud America 273
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 38
OC - Oceania 9
Totale 8.215
Nazione #
US - Stati Uniti d'America 4.724
SG - Singapore 793
CN - Cina 601
VN - Vietnam 226
BR - Brasile 217
UA - Ucraina 190
DE - Germania 161
IT - Italia 148
GB - Regno Unito 147
HK - Hong Kong 137
TR - Turchia 127
FI - Finlandia 62
FR - Francia 60
CA - Canada 52
SE - Svezia 49
BD - Bangladesh 42
RU - Federazione Russa 37
IN - India 36
ZA - Sudafrica 27
JP - Giappone 24
PL - Polonia 24
AR - Argentina 22
IQ - Iraq 19
PK - Pakistan 19
MX - Messico 18
NL - Olanda 13
CZ - Repubblica Ceca 11
ID - Indonesia 11
CO - Colombia 10
ES - Italia 10
EC - Ecuador 9
AU - Australia 8
AE - Emirati Arabi Uniti 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
VE - Venezuela 7
EG - Egitto 6
LT - Lituania 6
MA - Marocco 6
BE - Belgio 5
IR - Iran 5
JM - Giamaica 5
MY - Malesia 5
RO - Romania 5
CL - Cile 4
IL - Israele 4
PH - Filippine 4
DZ - Algeria 3
HR - Croazia 3
KE - Kenya 3
KG - Kirghizistan 3
MD - Moldavia 3
NP - Nepal 3
HN - Honduras 2
IE - Irlanda 2
JO - Giordania 2
KR - Corea 2
LY - Libia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GP - Guadalupe 1
GR - Grecia 1
HU - Ungheria 1
KW - Kuwait 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TG - Togo 1
TN - Tunisia 1
TW - Taiwan 1
Totale 8.178
Città #
Fairfield 505
Ashburn 497
Woodbridge 470
Singapore 451
San Jose 280
Houston 271
Seattle 223
Ann Arbor 221
Chandler 211
Jacksonville 210
Cambridge 183
Beijing 174
Santa Clara 168
Wilmington 166
Hong Kong 135
Los Angeles 90
New York 87
Ho Chi Minh City 83
Dallas 81
Nanjing 69
Izmir 66
Council Bluffs 55
Hanoi 50
Princeton 47
San Diego 37
Lauterbourg 36
Munich 36
Boardman 34
Milan 32
Shanghai 27
Buffalo 26
Shenyang 25
São Paulo 24
Nanchang 23
Tokyo 23
Ferrara 21
Orem 20
Warsaw 20
Johannesburg 17
Montreal 16
The Dalles 15
Tianjin 15
Changsha 14
London 14
Chicago 13
Da Nang 13
Falls Church 13
Jinan 13
San Mateo 13
Chennai 12
Poplar 12
Turku 12
Auburn Hills 11
Frankfurt am Main 11
Haiphong 11
Hebei 11
Mexico City 11
Mountain View 11
San Francisco 11
Zhengzhou 11
Toronto 10
Atlanta 9
Dearborn 9
Hefei 9
Manchester 9
Stockholm 9
Brooklyn 8
Falkenstein 8
Helsinki 8
Phoenix 8
Baghdad 7
Bremen 7
Brno 7
Columbus 7
Moscow 7
Philadelphia 7
Rome 7
Boston 6
Brasília 6
Guangzhou 6
Haikou 6
Ottawa 6
Redwood City 6
Rio de Janeiro 6
Vancouver 6
Amsterdam 5
Brussels 5
Bắc Ninh 5
Charlotte 5
Curitiba 5
Denver 5
Des Moines 5
Guarulhos 5
Istanbul 5
Jakarta 5
Kunming 5
Norwalk 5
Paris 5
Porto Alegre 5
Tappahannock 5
Totale 5.716
Nome #
Nutlin-3 up-regulates the expression of Notch1 in both myeloid and lymphoid leukemic cells, as part of a negative feedback antiapoptotic mechanism 264
Antiangiogenic activity of the MDM2 antagonist nutlin-3 254
Conjunctival sac fluid contains elevated levels of soluble TRAIL: implications for the anti-tumoral surveillance of the anterior surface of the eye 253
Association of tumor necrosis factor-related apoptosis-inducing ligand with total and cardiovascular mortality in older adults 248
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 235
Elevated levels of TRAIL in systemic lupus erythematosus are associated to the presence of anti-SSA/SSB antibodies 233
Human bone marrow mesenchymal stem cells display anti-cancer activity in SCID mice bearing disseminated non-hodgkin's lymphoma xenografts 231
Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes 228
Circulating levels of frizzled-related protein (FRZB) are increased in patients with early rheumatoid arthritis and decrease in response to disease-modifying antirheumatic drugs. 227
TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells 221
Is there any role for tumour necrosis factor related apoptosis inducing ligand–osteoprotegerin (TRAIL–OPG) interaction in rheumatoid arthritis? 216
TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release 215
In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. 212
Mesenchymal stem cells-derived vascular smooth muscle cells release abundant levels of osteoprotegerin 211
Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts 196
Tumor necrosis factor-related apoptosis-inducing ligand promotes migration of human bone marrow multipotent stromal cells 190
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells 190
Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. 188
TRAIL inhibits osteoclastic differentiation by counteracting RANKL-dependent p27Kip1 accumulation in pre-osteoclast precursors 185
Potential role of PKC inhibitors in the treatment of hematological malignancies 184
Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells 179
The tumour necrosis factor-related apoptosis inducing ligand-osteoprotegerin system in limited systemic sclerosis: a new disease marker? 173
TRAIL and osteoprotegerin: a role in endothelial physiopathology? 170
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice 169
Trail down-regulates the release of osteoprotegerin (OPG) by primary stromal cells 164
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction 164
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 161
TRAIL, caspases and maturation of normal and leukemic myeloid precursors 156
An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction 156
TNFRSF11B (tumor necrosis factor receptor superfamily, member 11b) 155
The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis 143
Metalloproteinase 2 cleaves in vitro recombinant TRAIL: Potential implications for the decreased serum levels of TRAIL after acute myocardial infarction 141
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells 139
Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand 127
Baseline serum concentrations of TRAIL in early rheumatoid arthritis: Relationship with response to disease-modifying antirheumatic drugs 127
Ruolo di trail nella patogenesi del danno neuronale indotto dalla proteina Tat di HIV-1 124
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 120
TNF-α modulates the migratory response of mesenchymal stem cells to TRAIL 112
null 102
Insulin down-regulates TRAIL expression in vascular smooth muscle cells both in vivo and in vitro 101
null 97
null 94
null 90
null 89
null 88
null 86
Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo 84
null 78
null 74
null 65
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 60
The potential role of Nutlins in the treatment of B-chronic lymphocytic leukemia (B-CLL) 46
Totale 8.215
Categoria #
all - tutte 34.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022507 0 57 56 11 15 26 35 25 14 29 66 173
2022/2023457 40 23 17 49 80 78 25 40 47 7 28 23
2023/2024197 16 26 3 5 11 51 9 13 1 3 3 56
2024/2025988 21 32 66 50 144 72 23 47 216 75 143 99
2025/20262.756 281 99 287 344 394 189 329 118 259 299 107 50
2026/2027137 58 79 0 0 0 0 0 0 0 0 0 0
Totale 8.215